NanHua Bio-medicine Co Ltd
SZSE:000504
Relative Value
The Relative Value of one NanHua Bio-medicine Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 8.62 CNY, NanHua Bio-medicine Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
NanHua Bio-medicine Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
N
|
NanHua Bio-medicine Co Ltd
SZSE:000504
|
2.8B CNY | 22.7 | -458.6 | -115.7 | -115.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
400.5B USD | 6.7 | 171.3 | 16.6 | 23.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
190.3B USD | 6.4 | 22.3 | 15.2 | 15.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.2B USD | 10 | 30.3 | 23.2 | 24.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.7B USD | 5.8 | 18.5 | 14.1 | 16.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
73.9B AUD | 3.3 | 17.1 | 11.7 | 14.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.3B EUR | 14.4 | 33.9 | 58.2 | 59.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |